Boston Scientific

Aktuelle Nachrichten

Schlagzeilen in der Originalsprache der Quelle.

• Bernstein Adjusts Boston Scientific Price Target to $54 From $60, Maintains Outperform Rating (öffnet in neuem Tab)

  marketscreener.com · 02.10.2026

• Elutia receives $8 million escrow from Boston Scientific sale (öffnet in neuem Tab)

  Investing.com · 01.10.2026

• Elutia Receives $8 Million Payment from Boston Scientific; Company Now Fully Funded into 2029 (öffnet in neuem Tab)

  Yahoo Finance · 01.10.2026

• Boston Scientific misses 2026 guidance as Boston Scientific stock faces a reset (öffnet in neuem Tab)

  ad-hoc-news.de · 01.10.2026

• Boston Scientific re-evaluates 2027 framework after cyberattack (öffnet in neuem Tab)

  scanx.trade · 01.10.2026

• Boston Scientific stock after-hours: company warns cyber incident may affect 2026 results (öffnet in neuem Tab)

  ad-hoc-news.de · 30.09.2026

• Boston Scientific's MedSurg Diversification Bolsters Growth Prospects (öffnet in neuem Tab)

  TradingView · 30.09.2026

• Boston Scientific (BSX) Files Motion to Dismiss Shareholder Securities Lawsuit (öffnet in neuem Tab)

  TipRanks · 30.09.2026

• Boston Scientific stock absorbs a USD 20.00 target cut (öffnet in neuem Tab)

  ad-hoc-news.de · 30.09.2026

• Boston Scientific stock ahead of the Xetra open as newsroom lists cybersecurity update (öffnet in neuem Tab)

  ad-hoc-news.de · 30.09.2026

• Spinal Cord Stimulator Lawsuit Alleges Boston Scientific Device Failure Required Removal Surgery (öffnet in neuem Tab)

  AboutLawsuits.com · 29.09.2026

• Boston Scientific Receives FDA clearance for SpaceOAR Flex Hydrogel (öffnet in neuem Tab)

  Med-Tech Insights · 29.09.2026

• Boston Scientific: Market Pessimism Has Pushed The Stock Into Undervalued Territory (NYSE:BSX) (öffnet in neuem Tab)

  Seeking Alpha · 29.09.2026

• Could Boston Scientific’s $300 Million Cyber Hit Be Mostly a 2026 Problem? (öffnet in neuem Tab)

  Insider Monkey · 28.09.2026

• Why Oppenheimer Cut Boston Scientific’s Price Target by $20 Despite Keeping its Outperform Rating (öffnet in neuem Tab)

  Insider Monkey · 28.09.2026

• Boston Scientific stock gains 2.06 percent ahead of the open (öffnet in neuem Tab)

  ad-hoc-news.de · 25.09.2026

• Boston Scientific stock slips before the bell after September 23 decline (öffnet in neuem Tab)

  ad-hoc-news.de · 24.09.2026

• Boston Scientific stock faces a weaker 2026 growth outlook (öffnet in neuem Tab)

  ad-hoc-news.de · 24.09.2026

• Boston Scientific stock advances 2.1 percent ahead of the open (öffnet in neuem Tab)

  ad-hoc-news.de · 23.09.2026

• Boston Scientific (BSX) Stock Moves 2.74%: What You Should Know (öffnet in neuem Tab)

  Yahoo Finance · 22.09.2026

• Boston Scientific stock holds steady as Oppenheimer cuts price target to USD 65 (öffnet in neuem Tab)

  ad-hoc-news.de · 21.09.2026

• Boston Scientific stock holds steady as analysts weigh cyberattack impact (öffnet in neuem Tab)

  ad-hoc-news.de · 20.09.2026

• Boston Scientific stock heads into the open after a Citi downgrade-driven drop (öffnet in neuem Tab)

  ad-hoc-news.de · 18.09.2026

• Citigroup Downgrades Boston Scientific to Neutral From Buy, Adjusts Price Target to $50 From $57 (öffnet in neuem Tab)

  marketscreener.com · 17.09.2026

• BSX vs. MDT: Which Electrophysiology Stock Is the Better Bet Now? (öffnet in neuem Tab)

  TradingView · 17.09.2026

• Citigroup Downgrades Boston Scientific to Neutral From Buy, Adjusts PT to $50 From $57 (öffnet in neuem Tab)

  Yahoo Finance · 17.09.2026

• Boston Scientific downgraded at Citi on increasing competition, cyberattack fallout (öffnet in neuem Tab)

  Seeking Alpha · 17.09.2026

• Citi downgrades Boston Scientific on uncertain recovery path (öffnet in neuem Tab)

  Yahoo Finance · 17.09.2026

• Boston Scientific Spine Stimulator Lawsuit Filed Over Numbness, Incontinence, Erectile Dysfunction (öffnet in neuem Tab)

  AboutLawsuits.com · 16.09.2026

• Boston Scientific stock falls after cyberattack guidance hit (öffnet in neuem Tab)

  ad-hoc-news.de · 16.09.2026